RARE DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE
· the rosen law firm pa
AI Briefing
- Investors in Ultragenyx Pharmaceutical Inc. securities have until April 6, 2026 to file a lead plaintiff motion in the class action lawsuit.
- A securities class action lawsuit has been filed against the company over alleged violations of federal securities laws.
- Ultragenyx Pharmaceutical Inc. investors are encouraged to contact Rosen Law Firm by April 6, 2026 to discuss their options.
Advertisement